Screener / SEC EDGAR /CIK 0000896622 /10-K filed Feb 6, 2026, compared with Feb 7, 2025 /Numbers from the XBRL of the 10-Ks
Materials peers:
NYSE Materials · Plastics Products

Aptargroup, Inc. ATR

Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. 10-K, Item 1

Headquarters
Crystal Lake, IL
CEO
Gael Touya
Next results
around Feb 4, 2027
Compare with peers Embed

ATR among Materials peers

Six ratios from the latest 10-K. Each corner is the share of 84 peers the company is above, not a score.

Compare
Revenue growth: 5.4%, above 57% of 84 peers (their median 3.6%) REVENUE GROWTH 5.4% · above 57% Operating margin: 11.9%, above 52% of 67 peers (their median 11.5%) OPERATING MARGIN 11.9% · above 52% Net margin: 6.7%, above 49% of 84 peers (their median 6.9%) NET MARGIN 6.7% · above 49% FCF margin: 7.4%, above 50% of 82 peers (their median 7.4%) FCF MARGIN 7.4% · above 50% Return on capital: 10.0%, above 60% of 53 peers (their median 8.4%) RETURN ON CAPITAL 10.0% · above 60%
ATR Peer median Below the median

What changed

7 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 6, 2026 against Feb 7, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

2facts worth reading about the other 9 checks found nothing to note

  • Receivables growing faster than revenue
    Receivables +22.2% ($658.1M to $803.8M) vs revenue +5.4% ($3.6B to $3.8B), +16.7 pts apart
  • Inventory growing faster than revenue
    Inventory +16.5% ($461.8M to $537.8M) vs revenue +5.4% ($3.6B to $3.8B), +11.0 pts apart
  • Cash from operations $570.0M vs net income $392.8M (FY ending Dec 31, 2025)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • No longer listed: Table of Contents. Same as last year: Goodwill Impairment Assessment - Beauty Reporting Unit; Revenue Recognition - Product Sales
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

7 paragraphs in Risk Factors that were not in the 10-K filed Feb 7, 2025. Quoted as filed.

All 7 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
    The rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks. In addition, as locally hosted information technology environments and data centers continue to decline or are decommissioned,we may increasingly rely on cloud-based solutions to host applications and data. Any…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
    A material failure or disruption at one or more of our manufacturing facilities could adversely affect our ability to generate sales and meet customer demand. Our ability to generate sales and meet customer demand depends on the continued operation of our manufacturing facilities, many of which involve complex, specialized, and highly…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
    We are exposed to risks from lawsuits and claims, including product liability claims, as well as investigations, audits and other proceedings, which may result in substantial costs and expenses or interruption of our normal business operations. We are subject to a number of lawsuits and claims that arise in the ordinary course of our…
  4. Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
    We are also from time to time subject to claims from third parties suggesting that we may be infringing on their intellectual property rights. For example, in May 2025, Nemera filed patent infringement actions against us in France and Germany relating to certain of our ophthalmic products. In October 2025, an EPO hearing invalidated…

New risk paragraphs, against peers

Latest 10-K of each, Materials companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$3.3B$3.5B$3.6B$3.8B
Net income$239.3M$284.5M$374.5M$392.8M
Operating cash flow$478.6M$575.2M$643.4M$570.0M
Free cash flow$168.2M$262.9M$366.9M$299.6M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$3.8B ▲ 5.4% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

3 filings in the last 30 days · SEC EDGAR

All filings

About the company

Aptargroup, Inc., Crystal Lake, IL · from the 10-K filed Feb 6, 2026

Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery. Aptar is headquartered in Crystal Lake, Illinois and has approximately 14,000 employees in approximately 20 different countries. For more information, visit www.aptar.com.

Headquarters
Crystal Lake, IL
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 29, 2026
Incorporated in
DE

Email alerts

Sources

The 10-K filed Feb 6, 2026 (open at SEC), compared with the 10-K filed Feb 7, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ATR/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.